Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday - two days after it announced the new drug following the Food and Drug Administration's threat to restrict access to the ingredients needed to copy popular weight-loss medications.
